DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter

Biochemical Journal

Volumn 422, Issue 3, 2009, Pages 543-551

  Liu, Hanshao ^a   Hew, Hoi Chin ^a   Lu, Zheng Guang ^a   Yamaguchi, Tomoko ^a   Miki, Yoshio ^a   Yoshida, Kiyotsugu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; DNA damage; p53; Ras responsive element binding protein 1 (RREB 1); Transcription

Indexed keywords

APOPTOSIS; CORE PROMOTERS; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA DAMAGE SIGNALLING; DNA DAMAGES; ELEMENT-BINDING PROTEINS; GENOTOXIC STRESS; MOLECULAR BASIS; P53; PROTEIN LEVEL; RAS-RESPONSIVE ELEMENT-BINDING PROTEIN-1 (RREB-1); TARGET GENES; TRANSCRIPTIONAL REGULATION; TUMOUR SUPPRESSOR; TUMOUR SUPPRESSOR GENES;

CELL DEATH; DNA; GENES; NUCLEIC ACIDS; TUMORS;

TRANSCRIPTION;

BETA ACTIN; BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG; BROXURIDINE; DNA BINDING PROTEIN; RREB1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GENE DISRUPTION; GENE SILENCING; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; GENETICS; IMMUNOBLOTTING; METABOLISM; NICK END LABELING; PHYSIOLOGY; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

APOPTOSIS; BROMODEOXYURIDINE; CELL CYCLE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 70249118941     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090342     Document Type: Article

References (42)

1. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. and Vogelstein, B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915
2. Finlay, C. A., Hinds, P. W. and Levine, A. J. (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57, 1083-1093
3. Sherr, C. J. (2004) Principles of tumour suppression. Cell 116, 235-246
4. Vogelstein, B. and Kinzler, K. W. (2004) Cancer genes and the pathways they control. Nat. Med. 10, 789-799
5. Vogelstein, B., Lane, D. and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
6. Vousden, K. H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604
7. Yoshida, K. (2008) Nuclear trafficking of pro-apoptotic kinases in response to DNA damage. Trends Mol. Med. 14, 305-313
8. Taira, N., Nihira, K., Yamaguchi, T., Miki, Y. and Yoshida, K. (2007) DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol. Cell 25, 725-738
9. Brooks, C. L. and Gu, W. (2006) p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307-315
10. Kubbutat, M. H., Jones, S. N. and Vousden, K. H. (1997) Regulation of p53 stability by Mdm2. Nature 387, 299-303
11. Prives, C. (1998) Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8
12. Freedman, D. A., Wu, L. and Levine, A. J. (1999) Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci. 55, 96-107
13. Bode, A. M. and Dong, Z. (2004) Post-translational modification of p53 in tumourigenesis. Nat. Rev. Cancer 4, 793-805
14. Takagi, M., Absalon, M. J., McLure, K. G. and Kastan, M. B. (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123, 49-63
15. Raman, V., Martensen, S. A., Reisman, D., Evron, E., Odenwald, W. F., Jaffee, E., Marks, J. and Sukumar, S. (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405, 974-978
16. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K. and Taniguchi, T. (2003) Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523
17. Liu, D. X. and Lobie, P. E. (2007) Transcriptional activation of p53 by Pitx1. Cell Death Differ. 14, 1893-1907
18. Liu, H., Lu, Z. G., Miki, Y. and Yoshida, K. (2007) Protein kinase C delta induces transcription of the TP53 tumour suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Mol. Cell. Biol. 27, 8480-8491
19. Yoshida, K., Liu, H. and Miki, Y. (2006) Protein Kinase Cδ regulates Ser46 phosphorylation of p53 tumour suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 281, 5734-5740
20. Phan, R. T. and Dalla-Favera, R. (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635-639
21. Wang, S. and El-Deiry, W. S. (2006) p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints. Cancer Res. 66, 6982-6989
22. Yoshida, K., Komatsu, K., Wang, H. G. and Kufe, D. (2002) c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage. Mol. Cell. Biol. 22, 3292-3300
23. Yoshida, K., Wang, H. G., Miki, Y. and Kufe, D. (2003) Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J. 22, 1431-1441
24. Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D. and Miki, Y. (2005) JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol. 7, 278-285
25. Yoshida, K., Yamaguchi, T., Shinagawa, H., Taira, N., Nakayama, K. I. and Miki, Y. (2006) Protein kinase Cδ activates topoisomerase IIα to induce apoptotic cell death in response to DNA damage. Mol. Cell. Biol. 26, 3414-3431
26. Yoshida, K. and Kufe, D. (2001) Negative regulation of the SHPTP1 protein tyrosine phosphatase by protein kinase Cδ in response to DNA damage. Mol. Pharmacol. 60, 1431-1438
27. Yoshida, K., Kharbanda, S. and Kufe, D. (1999) Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage. J. Biol. Chem. 274, 34663-34668
28. Yoshida, K., Weichselbaum, R., Kharbanda, S. and Kufe, D. (2000) Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage. Mol. Cell. Biol. 20, 5370-5380
29. Yoshida, K., Miki, Y. and Kufe, D. (2002) Activation of SAPK/JNK signaling by protein kinase Cδ in response to DNA damage. J. Biol. Chem. 277, 48372-48378
30. Yamaguchi, T., Kimura, J., Miki, Y. and Yoshida, K. (2007) The deubiquitinating enzyme USP11 controls an IKKα-p53 signaling pathway in response to TNFα. J. Biol. Chem. 282, 33943-33948
31. Yamaguchi, T., Miki, Y. and Yoshida, K. (2007) Protein kinase C delta activates IκB-kinase α to induce the p53 tumour suppressor in response to oxidative stress. Cell. Signalling 19, 2088-2097
32. Sun, X., Shimizu, H. and Yamamoto, K. (1995) Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol. Cell. Biol. 15, 4489-4496
33. Boggs, K. and Reisman, D. (2006) Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter. Oncogene 25, 555-565
34. Thiagalingam, A., De Bustros, A., Borges, M., Jasti, R., Compton, D., Diamond, L., Mabry, M., Ball, D. W., Baylin, S. B. and Nelkin, B. D. (1996) RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol. Cell. Biol. 16, 5335-5345
35. Zhang, L., Zhao, J. and Edenberg, H. J. (1999) A human Raf-responsive zinc-finger protein that binds to divergent sequences. Nucleic Acids Res. 27, 2947-2956
36. Fujimoto-Nishiyama, A., Ishii, S., Matsuda, S., Inoue, J. and Yamamoto, T. (1997) A novel zinc finger protein, Finb, is a transcriptional activator and localized in nuclear bodies. Gene 195, 267-275
37. Ray, S. K., Nishitani, J., Petry, M. W., Fessing, M. Y. and Leiter, A. B. (2003) Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1. Mol. Cell. Biol. 23, 259-271
38. Zhang, S., Qian, X., Redman, C., Bliskovski, V., Ramsay, E. S., Lowy, D. R. and Mock, B. A. (2003) p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 22, 2285-2295
39. Date, S., Nibu, Y., Yanai, K., Hirata, J., Yagami, K. and Fukamizu, A. (2004) Finb, a multiple zinc finger protein, represses transcription of the human angiotensinogen gene. Int. J. Mol. Med. 13, 637-642
40. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A. and Shi, Y. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953
41. Reisman, D. and Loging, W. T. (1998) Transcriptional regulation of the p53 tumour suppressor gene. Semin. Cancer Biol. 8, 317-324
42. Tuck, S. P. and Crawford, L. (1989) Characterization of the human p53 gene promoter. Mol. Cell. Biol. 9, 2163-2172